英国Maybridge
Maybridge是Thermo Fisher Scientific 集团下专为药物研发和生物技术提供相关产品和服务的品牌,一直致力于为客户设计和提供创新性杂环中间体,医药化学服务和筛选化合物库以帮助客户发现和设计新的有价值的药物分子,助力药物发现工作。
2002年Fisher Scientific 收购英国Maybridge
1962
The story begins in Cornwall, UK when Maybridge Chemical Company was founded in Tintagel by the organic chemist, Dr. R. J. Bridgwater. The company is named after his wife Gladys MAY BRIDG(E)water.
1971
The company moved to its present location at Trevillett, at that time the site of a disused slate quarry, in an area of outstanding natural beauty in North Cornwall.
1997
Dr. Bridgwater sold the business to venture capitalists 3i plc in a Management Buy-In/Buy-Out transaction headed by Dr. Roger Newton.
2002
Maybridge was acquired by Fisher Scientific International.
Although much has changed since the formation of the company, chemistry at Maybridge is still based on the search for bioactive molecules.
Maybridge has built a reputation for creating innovative organic molecules for drug discovery - over 56,000 Screening Compounds and an expanding range of highly reactive Building Blocks. These building blocks, and the expertise gained in the design and synthesis of the collection, underpin the products and services that Maybridge offers.
Now that you've found Maybridge... you have found a sure way to expedite your research. Maybridge offers a wide variety of premier products and services including a diverse range of Building Blocks, Medicinal Chemistry services and our renowed Screening Collections including the HitFinderTM and Ro3 Fragment Collection. All of our compounds are either synthesized in our facility or outsourced through trusted suppliers, which means we can supply you with larger quantities when you need them. Our expertise also means we are ready to partner with you to create new compounds or libraries. With over 45 years of synthesis of novel heterocycles, our skill with medicinal chemistry can be used to give you the leading edge.
Now that you've discovered Maybridge, may your next discovery be right around the corner.